Via Pharmaceuticals, Inc.
Records under this name other than patents Via Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Via Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,153,644 | Diacylglycerol acyltransferase inhibitors Formerly held Lapsed on the fee record Ended Apr 10, 2024 · USPTO record | Lapsed on the fee record | Ended Apr 10, 2024 | USPTO record |
| US 8,124,766 | Inhibitors of diacylglycerol acyltransferase Formerly held Lapsed on the fee record Ended Feb 28, 2024 · USPTO record | Lapsed on the fee record | Ended Feb 28, 2024 | USPTO record |
| US 8,115,011 | Diacylglycerol acyltransferase inhibitors Formerly held Lapsed on the fee record Ended Feb 14, 2024 · USPTO record | Lapsed on the fee record | Ended Feb 14, 2024 | USPTO record |
| US 8,058,299 | Diacylglycerol acyltransferase inhibitors Formerly held Lapsed on the fee record Ended Nov 15, 2023 · USPTO record | Lapsed on the fee record | Ended Nov 15, 2023 | USPTO record |
| US 8,324,385 | Diacylglycerol acyltransferase inhibitors Formerly held Lapsed on the fee record Ended Dec 4, 2020 · USPTO record | Lapsed on the fee record | Ended Dec 4, 2020 | USPTO record |
| US 8,211,884 | Diacylglycerol acyltransferase inhibitors Formerly held Lapsed on the fee record Ended Jul 3, 2020 · USPTO record | Lapsed on the fee record | Ended Jul 3, 2020 | USPTO record |
| US 8,211,914 | Inhibitors of diacylglycerol acyltransferase Formerly held Lapsed on the fee record Ended Jul 3, 2020 · USPTO record | Lapsed on the fee record | Ended Jul 3, 2020 | USPTO record |
| US 7,714,126 | Diacylglycerol acyltransferase inhibitors Formerly held Lapsed on the fee record Ended May 11, 2018 · USPTO record | Lapsed on the fee record | Ended May 11, 2018 | USPTO record |
| US 7,495,024 | Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque Formerly held Lapsed on the fee record Ended Feb 24, 2017 · USPTO record | Lapsed on the fee record | Ended Feb 24, 2017 | USPTO record |
| US 7,485,752 | Diacylglycerol acyltransferase inhibitors Lapsed on the fee record Ended Feb 3, 2013 · USPTO record | Lapsed on the fee record | Ended Feb 3, 2013 | USPTO record |